TOKYO — Japanese medical equipment maker Terumo has launched a corporate venture capital fund that will invest $75 million in advanced cardiovascular treatment technologies with an eye on potential mergers and acquisitions in the future.
The Terumo Ventures division was launched as a subsidiary of Terumo Americas Holding. They will also set up bases in Boston and Silicon Valley, California, as well as Belgium.
